Fundraising FoxAxentbio
Berkeley, US · 1 known investors
Find your way into Axentbio
Sign up to see every warm intro you have to Axentbio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Axentbio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Axent Biosciences develops stem cell therapies to treat diseases like Parkinson's, using a proprietary cell cultivation platform to enable scalable and cost-effective manufacturing. The company was spun out of UC Berkeley research and aims to make stem cell therapies broadly accessible.
Founders & leadership
DS
David SchafferProfessor
Investors · 1
venBio Partnerslisted by venBio PartnersSan Francisco
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Axentbio do?
- Axent Biosciences develops stem cell therapies to treat diseases like Parkinson's, using a proprietary cell cultivation platform to enable scalable and cost-effective manufacturing. The company was spun out of UC Berkeley research and aims to make stem cell therapies broadly accessible.
- Who founded Axentbio?
- Axentbio was founded by David Schaffer.
- Who are Axentbio's investors?
- Axentbio's investors include venBio Partners.
- Where is Axentbio headquartered?
- Axentbio is headquartered in Berkeley, US.